Victoria Pak, associate professor in the School of Nursing and senior author of the study.
Photo Credit: Courtesy of Emory University
Scientific Frontline: Extended "At a Glance" Summary: High-Dose Vitamin D and Cognitive Function
The Core Concept: Recent research indicates that high-dose vitamin D supplementation (5,000 IU or more daily) may be associated with improved cognitive function in adults experiencing mild cognitive impairment (MCI) and sleep disturbances.
Key Distinction/Mechanism: Unlike general vitamin D supplementation, this study focuses on a critical intervention window—adults with MCI, an intermediate stage before dementia—suggesting that high daily doses can positively influence cognitive health during early decline, whereas lower doses did not show similar benefits.
Origin/History: The study, published in Sleep Medicine and funded by the National Institute on Aging, was conducted by researchers at Emory University's Nell Hodgson Woodruff School of Nursing.
Major Frameworks/Components:
- Study Population: 54 adults exhibiting mild cognitive impairment and sleep disturbances.
- Intervention: Daily intake of 5,000 IU or more of vitamin D (D2 or D3).
- Assessment: The Montreal Cognitive Assessment (MoCA), a widely used screening tool for memory and thinking skills.
- Outcomes: Participants taking high-dose vitamin D scored more than 13% higher on the MoCA compared to those who did not.
Branch of Science: Neuroscience, Gerontology, Nutritional Science, and Nursing.
Future Application: The findings could lead to the development of accessible, low-cost dietary interventions utilizing high-dose vitamin D supplements to support brain health and potentially delay or mitigate the progression of Alzheimer's disease in high-risk populations.
Why It Matters: With Alzheimer's dementia affecting over 7 million Americans and rates projected to rise significantly, identifying early, modifiable factors like vitamin D intake could offer a crucial strategy for preserving cognitive function and improving the quality of life for aging populations.
With more than 7 million Americans living with Alzheimer’s dementia—a number projected to reach nearly 13 million by 2050—new Emory University research suggests that higher vitamin D supplement intake may be associated with better cognitive function in adults with an elevated risk of dementia.
In a study of 54 adults with sleep disturbances and mild cognitive impairment (MCI), two hallmarks of early dementia, participants taking at least 5,000 IU of vitamin D daily showed better cognitive function compared with those who did not.
The study, recently published in Sleep Medicine, found that participants who reported taking 5,000 IU or more of vitamin D daily scored more than 13% higher on the Montreal Cognitive Assessment (MoCA) than those who did not, even after accounting for other factors. A screening tool to detect the risk of developing dementia, the MoCA is widely used to assess memory and thinking skills. In this study, lower daily doses of vitamin D were not associated with higher cognitive scores.
The study also emphasizes the significance of timing. MCI is an intermediate stage between normal cognitive aging and dementia.
“In older adults experiencing both sleep disturbance and mild cognitive impairment, this may represent a critical window for intervention, when cognitive changes are emerging but opportunities to support brain health may remain,” said Victoria Pak, senior author of the study.
“Identifying accessible and modifiable factors, such as vitamin D supplement intake, during the earlier stages of cognitive decline may become increasingly important, particularly as rates of Alzheimer’s disease continue to rise,” added Pak, an associate professor at Emory University’s Nell Hodgson Woodruff School of Nursing.
In addition to the timing of the intervention, the study found that cognitive performance did not differ based on the form of vitamin D—D2, typically derived from plants or fungi, or D3, produced after sun exposure or consuming animal-based foods.
Vitamin D, an essential nutrient, not only is necessary for muscle and nerve function but also influences sleep quality and sleep-wake cycles. Additionally, fifty percent of those with moderate to severe Alzheimer’s disease report having sleep disturbances, indicating a bidirectional relationship between sleep deprivation and cognitive decline.
While vitamin D deficiency has been implicated in sleep disorders, such as insomnia and increased nighttime awakenings, this preliminary study is the first to assess the relationship between vitamin D supplement intake and cognitive function in a high-risk population with both MCI and sleep disturbances.
Funding: This study was funded by the National Institute on Aging of the National Institutes of Health (grant numbers R01AG097853-01 and R61AG080606).
Published in journal: Sleep Medicine
Authors: Sirui Zhou, Paul Sudeshna, Lynn Marie Trotti, Donald Bliwise, and Victoria Pak
Source/Credit: Emory University
Edited by: Scientific Frontline
Reference Number: ns081926_02
